TickerFacts.

Company research / KMTS

Kestra Medical Technologies, Ltd. (KMTS)

Build a valuation ↗↓ Download CSV

SEC name KESTRA MEDICAL TECHNOLOGIES, LTD. · CIK 0001877184 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Fiscal year ends Apr 30

For the year ended 2026-04-30, Kestra Medical Technologies, Ltd. reported revenue of $95.13M. Revenue grew 59.0% from the prior annual period. Over the twelve months to 2026-07-31, revenue was $106.73M.

Key ratios (year ended 2026-04-30)

51.4%
Gross margin
-141.6%
Operating margin
-138.4%
Net margin
-50.7%
Return on year-end equity
59.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-01

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-07-31 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-07-31		2026-04-302025-04-302024-04-30
Revenue$106.73M$95.13M$59.81M$27.81M
Cost of Revenue$49.22M$46.26M$35.60M$27.45M
Gross Profit$57.51M$48.86M$24.21M$362.0K
R&D Expense$22.28M$19.48M$15.65M$15.49M
Operating Income-$143.52M-$134.74M-$106.38M-$85.06M
Depreciation & Amortization$9.35M$8.71M$7.97M$11.56M
EBITDA-$134.18M-$126.03M-$98.41M-$73.50M
Net Income-$149.87M-$131.61M-$113.81M-$94.12M
EPS (Diluted)n/a-$2.43-$5.13-$5.07
Total Assets$347.36M$358.46M$295.74M$45.95M
Total Liabilities$125.00M$98.81M$90.34M$78.22M
Shareholders' Equity$222.36M$259.66M$205.41M-$209.38M
Cash & Equivalents$68.56M$99.71M$237.59M$8.25M
Operating Cash Flow-$87.72M-$81.70M-$77.61M-$72.23M
Capital Expenditures$35.06M$34.89M$22.94M$12.23M
Free Cash Flow-$122.78M-$116.59M-$100.54M-$84.46M
Shares Outstanding59.27M58.38M51.35Mn/a
Weighted Average Diluted Sharesn/a54.18M24.58M19.89M
EPS (Basic)n/a-$2.43-$5.13-$5.07

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView